Skip to main content
CSTE
NASDAQ Manufacturing

Caesarstone Narrows Q2 Loss, but New U.S. Tariffs Cloud the Path to Profitability

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Building Materials Stocks · Materials
Sentiment info
Negative
Importance info
8
Price
$2.31
Mkt Cap
$79.7M
52W Low
$0.558
52W High
$2.62
52W Position info
314% above low
Off High info
12% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CSTE has more than doubled off its 52-week low of $0.558.

Summary

Caesarstone reported a narrower Q2 loss with improved margins, but new U.S. tariffs on quartz imports effective August 15 create fresh uncertainty, delaying the expected return to positive Adjusted EBITDA.


Key Events · Earnings and Guidance · CSTE

  • Q2 Revenue Down 4.5%

    Revenue fell to $96.6M from $101.1M a year ago, driven by soft North American demand, partially offset by strength in Australia.

  • Gross Margin Improves to 24%

    Gross margin expanded to 24.0% from 19.6% YoY, reflecting cost savings from the Bar-Lev facility closure and a refund of previously paid U.S. IEEPA tariffs.

  • Adjusted EBITDA Loss Narrows

    Adjusted EBITDA loss improved to $1.0M from $6.4M YoY, but the company is reassessing the timing of positive Adjusted EBITDA due to new U.S. tariffs.

  • New U.S. Tariffs Threaten Recovery

    A four-year tariff-rate quota on quartz surface imports takes effect August 15, 2026, with a 25% tariff within the 13M sqm annual quota and 50% above, impacting ~44% of revenue sourced from the U.S. market.


Analysis · CSTE · Manufacturing

Operational progress is evident in Caesarstone's Q2 results, with gross margin climbing to 24% and the Adjusted EBITDA loss shrinking to just $1M. However, a newly announced U.S. quartz tariff-rate quota, effective August 15, threatens to derail the turnaround. With 44% of revenue coming from the U.S., the 25% tariff within quota and 50% above could significantly raise costs, forcing the company to reassess its timeline for positive Adjusted EBITDA. The $51.2M silicosis provision and ongoing litigation remain a heavy overhang, though the company has no debt and $51.8M in cash.

At the time of this filing, CSTE was trading at $2.31 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $79.7M. The 52-week trading range was $0.56 to $2.62. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CSTE - Latest Insights

CSTE
Aug 05, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $2.31
Real-time Price: $2.31 info
Change: $0 (0%) info
Market Cap: $79.7M info
CSTE
May 13, 2026, 8:51 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.32
Real-time Price: $2.31 info
Change: +$0.990 (+75%) info
Market Cap: $79.7M info
CSTE
May 13, 2026, 7:12 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.32
Real-time Price: $2.31 info
Change: +$0.990 (+75%) info
Market Cap: $79.7M info
CSTE
Mar 04, 2026, 5:13 PM EST
Filing Type: 20-F
Importance Score:
10
Price at Filing: $0.9212
Real-time Price: $2.31 info
Change: +$1.39 (+151%) info
Market Cap: $79.7M info
CSTE
Mar 04, 2026, 9:18 AM EST
Filing Type: 6-K
Importance Score:
10
Price at Filing: $1.17
Real-time Price: $2.31 info
Change: +$1.14 (+97%) info
Market Cap: $79.7M info